"mRNA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonSanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine - Fierce Biotech
Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine Fierce Biotech
Defending Against the Next Bioweapon: the mRNA Imperative - War on the Rocks
Defending Against the Next Bioweapon: the mRNA Imperative War on the Rocks
Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine - CIDRAP
Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine CIDRAP
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigationa...
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) ACCESS Newswire
Sanofi vows to stay committed to vaccines as portfolio takes a hit - Endpoints News
Sanofi vows to stay committed to vaccines as portfolio takes a hit Endpoints News
Moderna's latest CMO steps down after barely a year - Fierce Biotech
Moderna's latest CMO steps down after barely a year Fierce Biotech
Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis - Stanford Medicine
Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis Stanford Medicine
This innovation saved lives in the pandemic. Now it’s showing strength against cancer. - The Wash...
This innovation saved lives in the pandemic. Now it’s showing strength against cancer. The Washington Post
Bayer sues COVID vaccine makers over mRNA technology - Reuters
Bayer sues COVID vaccine makers over mRNA technology Reuters
Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation - ScienceDaily
Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation ScienceDaily
Biopharma bites: Regeneron's 4Q results, Recordati's mRNA deal, plus new leadership at Moderna, N...
Biopharma bites: Regeneron's 4Q results, Recordati's mRNA deal, plus new leadership at Moderna, Novo Nordisk FirstWord Pharma
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer - UF...
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer UF Health
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence - BioSpace
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence BioSpace
Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target - Mount Sinai
Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target Mount Sinai
Rare metabolic disease drug mRNA-3927 draws up to $160M Moderna-Recordati pact - Stock Titan
Rare metabolic disease drug mRNA-3927 draws up to $160M Moderna-Recordati pact Stock Titan
Moderna and Recordati collaborate on rare disease mRNA therapy - European Pharmaceutical Review
Moderna and Recordati collaborate on rare disease mRNA therapy European Pharmaceutical Review
World-changing mRNA vaccines - Penn Medicine
World-changing mRNA vaccines Penn Medicine
Privium Fund Management B.V. Lowers Holdings in Moderna, Inc. $MRNA - MarketBeat
Privium Fund Management B.V. Lowers Holdings in Moderna, Inc. $MRNA MarketBeat
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive datase...
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset Nature
$MRNA stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
$MRNA stock is down 8% today. Here's what we see in our data. Quiver Quantitative
HHS Winds Down mRNA Vaccine Development Under BARDA - HHS.gov
AstraZeneca looks to China for obesity drug candidates - statnews.com
AstraZeneca looks to China for obesity drug candidates statnews.com
Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M - BioSpace
Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M BioSpace
91,010 Shares in Moderna, Inc. $MRNA Purchased by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
91,010 Shares in Moderna, Inc. $MRNA Purchased by Mitsubishi UFJ Trust & Banking Corp MarketBeat
Moderna offloads late-stage rare disease drug for $50M upfront - Fierce Biotech
Moderna offloads late-stage rare disease drug for $50M upfront Fierce Biotech
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA s...
The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editoria...
The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editorial The Guardian
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - MD Anderson C...
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy MD Anderson Cancer Center
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine The New England Journal of Medicine
Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know Yahoo Finance
New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public ...
New report sounds alarm on health fallout from mRNA vaccine funding cuts Yale School of Public Health
Answering common questions on mRNA technology - PhRMA
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) (NASDAQ:MRNA) - Seeking ...
Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) (NASDAQ:MRNA) Seeking Alpha
Moderna announces departure of medical chief (MRNA:NASDAQ) - Seeking Alpha
Moderna announces departure of medical chief (MRNA:NASDAQ) Seeking Alpha
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate CEPI
Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA v...
Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination Science | AAAS
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus CEPI
US abandons mRNA vaccine development despite triumphs - European AIDS Treatment Group
US abandons mRNA vaccine development despite triumphs European AIDS Treatment Group
Could COVID-19 mRNA vaccines help treat cancer? - Oncology Central
Could COVID-19 mRNA vaccines help treat cancer? Oncology Central
People with some cancers live longer after a COVID vaccine - Nature
People with some cancers live longer after a COVID vaccine Nature
Slashing of funding for mRNA vaccine development raises concern - Harvard T.H. Chan School of Pub...
Slashing of funding for mRNA vaccine development raises concern Harvard T.H. Chan School of Public Health
Understanding the Impact of Federal Cuts to mRNA Vaccine Research - American Lung Association
Understanding the Impact of Federal Cuts to mRNA Vaccine Research American Lung Association
Moderna (MRNA) Shares Skyrocket, What You Need To Know - Yahoo Finance
Moderna (MRNA) Shares Skyrocket, What You Need To Know Yahoo Finance
mRNA COVID vaccines tied to drop in death rate for 4 years - CIDRAP
mRNA COVID vaccines tied to drop in death rate for 4 years CIDRAP
News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising ...
News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments Johns Hopkins Medicine
Deep generative models design mRNA sequences with enhanced translational capacity and stability -...
Deep generative models design mRNA sequences with enhanced translational capacity and stability Science | AAAS
Giving mRNA vaccines a technological shot in the arm - YaleNews
Giving mRNA vaccines a technological shot in the arm YaleNews
The Prevalence and Policy Consequences of "mRNA Vaccine Stigmatization" in the US - Harvard T.H. ...
The Prevalence and Policy Consequences of "mRNA Vaccine Stigmatization" in the US Harvard T.H. Chan School of Public Health
mRNA-antibody combination treatment keeps melanoma at bay, study finds - BioXconomy
mRNA-antibody combination treatment keeps melanoma at bay, study finds BioXconomy
Restoring youth to old immune cells: mRNA therapy turns back the clock - Nature
Restoring youth to old immune cells: mRNA therapy turns back the clock Nature
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer - UF Health
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer UF Health
HHS Abandons mRNA Vaccines, Experts Warn of Threats to U.S. Health Security - Global Biodefense
HHS Abandons mRNA Vaccines, Experts Warn of Threats to U.S. Health Security Global Biodefense
RNA stability enhancers for durable base-modified mRNA therapeutics - Nature
RNA stability enhancers for durable base-modified mRNA therapeutics Nature
How Cuts to mRNA Vaccine Development Will Set the U.S. Back - Johns Hopkins Bloomberg School of P...
How Cuts to mRNA Vaccine Development Will Set the U.S. Back Johns Hopkins Bloomberg School of Public Health
Interesting MRNA Put And Call Options For March 13th - Nasdaq
How fast mRNA degrades linked to autoimmune disease risk - Newsroom | UCLA
How fast mRNA degrades linked to autoimmune disease risk Newsroom | UCLA
mRNA COVID vaccines may be helping some cancer patients fight tumors, researchers say - PBS
mRNA COVID vaccines may be helping some cancer patients fight tumors, researchers say PBS
Halting mRNA Research Could Deepen the Public’s Distrust and Uncertainty about Vaccine Safety – w...
mRNA-based SARS-CoV-2 vaccines: The intracellular aggregation of encoded spike monomers and their...
Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animal...
Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals Nature
Experimental mRNA flu vaccine is more effective than conventional flu shot, but causes more side ...
A look at how mRNA vaccines work as RFK Jr. cancels government-funded research - PBS
A look at how mRNA vaccines work as RFK Jr. cancels government-funded research PBS
Cancelling mRNA studies is the highest irresponsibility - Nature
Cancelling mRNA studies is the highest irresponsibility Nature
Exclusive: RFK Jr cancelled mRNA research — but the US military is still funding it - Nature
Exclusive: RFK Jr cancelled mRNA research — but the US military is still funding it Nature
In My Words: The future of vaccine science is spelled mRNA - Elon University
In My Words: The future of vaccine science is spelled mRNA Elon University
Future mRNA vaccines may prevent food and seasonal allergies - Penn Medicine
Future mRNA vaccines may prevent food and seasonal allergies Penn Medicine
New NIST Research Grade Test Material to support mRNA therapeutics - National Institute of Standa...
New NIST Research Grade Test Material to support mRNA therapeutics National Institute of Standards and Technology (.gov)
Sinergium paves the way for Latin American mRNA vaccines with new preclinical study - CEPI
Sinergium paves the way for Latin American mRNA vaccines with new preclinical study CEPI
mRNA Vaccines Explained: What Older Adults Should Know - The National Council on Aging (NCOA)
mRNA Vaccines Explained: What Older Adults Should Know The National Council on Aging (NCOA)
Compact polyethylenimine-complexed mRNA vaccines - Nature
Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...
An mRNA vaccine encoding five conserved Group A Streptococcus antigens - Nature
An mRNA vaccine encoding five conserved Group A Streptococcus antigens Nature
mRNA Vaccines and Older Adults: What to Know - The National Council on Aging (NCOA)
mRNA Vaccines and Older Adults: What to Know The National Council on Aging (NCOA)
New mRNA Vaccine Is More Effective and Less Costly to Develop, Pitt Study Finds - University of P...
New mRNA Vaccine Is More Effective and Less Costly to Develop, Pitt Study Finds University of Pittsburgh
RFK Jr cancels $500m in mRNA vaccine development in the US - BBC
RFK Jr cancels $500m in mRNA vaccine development in the US BBC
Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis - Scientific American
Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis Scientific American
Commentary: mRNA technology has cancer in its sights - Johns Hopkins University
Commentary: mRNA technology has cancer in its sights Johns Hopkins University
Latin America and the Caribbean advance mRNA vaccine development against influenza A(H5N1) with P...
Latin America and the Caribbean advance mRNA vaccine development against influenza A(H5N1) with PAHO support Pan American Health Organization (PAHO)
Assessing Moderna (MRNA) Valuation After Promising Melanoma Vaccine Data With Keytruda - simplywa...
Assessing Moderna (MRNA) Valuation After Promising Melanoma Vaccine Data With Keytruda simplywall.st
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? (MRNA) - Seek...
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? (MRNA) Seeking Alpha
mRNA vaccines for HIV trigger strong immune response in people - Nature
mRNA vaccines for HIV trigger strong immune response in people Nature
Moderna (MRNA) Announces Leadership Changes Amid Strategic Shift - GuruFocus
Moderna (MRNA) Announces Leadership Changes Amid Strategic Shift GuruFocus
Moderna, Inc. $MRNA Stock Holdings Reduced by Universal Beteiligungs und Servicegesellschaft mbH ...
Moderna, Inc. $MRNA Stock Holdings Reduced by Universal Beteiligungs und Servicegesellschaft mbH MarketBeat
mRNA Vaccines Are a Game Changer—Here’s Why - Scientific American
mRNA Vaccines Are a Game Changer—Here’s Why Scientific American
Trans amplifying mRNA vaccine expressing consensus spike elicits broad neutralization of SARS CoV...
Study suggests mRNA COVID-19 vaccines can improve chances of cancer survival - Gavi, the Vaccine ...
Study suggests mRNA COVID-19 vaccines can improve chances of cancer survival Gavi, the Vaccine Alliance
House appropriators snub Kennedy, include mRNA vaccine funding in spending bill - statnews.com
House appropriators snub Kennedy, include mRNA vaccine funding in spending bill statnews.com
Federal mRNA funding cut is 'most dangerous public health decision' ever, expert says - PBS
Federal mRNA funding cut is 'most dangerous public health decision' ever, expert says PBS
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer - Pharmacy Times
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer Pharmacy Times
What to know about mRNA vaccines as Trump admin pulls funding - Axios
What to know about mRNA vaccines as Trump admin pulls funding Axios
NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology - sta...
NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology statnews.com
5 things to know about the power of mRNA technology - Hopkins Bloomberg Center
5 things to know about the power of mRNA technology Hopkins Bloomberg Center
How RFK Jr.’s misguided science on mRNA vaccines is shaping policy − a vaccine expert examines th...
WHO says US ending mRNA vaccine contracts a ‘significant blow’ - Al Jazeera
WHO says US ending mRNA vaccine contracts a ‘significant blow’ Al Jazeera
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines - Nature
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines Nature
BioNTech’s mRNA pivot drives fresh investor optimism - Longevity.Technology
BioNTech’s mRNA pivot drives fresh investor optimism Longevity.Technology
Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no ex...
Surprising finding could pave way for universal cancer vaccine - UF Health
Surprising finding could pave way for universal cancer vaccine UF Health
‘Stealthy’ lipid nanoparticles give mRNA vaccines a makeover - Cornell Chronicle
‘Stealthy’ lipid nanoparticles give mRNA vaccines a makeover Cornell Chronicle